Hypogalactosylation of serum IgG in patients with coeliac disease
- PMID: 12930370
- PMCID: PMC1808795
- DOI: 10.1046/j.1365-2249.2003.02220.x
Hypogalactosylation of serum IgG in patients with coeliac disease
Abstract
Coeliac disease (CD) is described as an autoimmune enteropathy associated with the presence of IgG and IgA antigliadin and antitransglutaminase autoantibodies. While of diagnostic significance, the role of these autoantibodies in the immunopathogenesis of CD is elucidated. An inappropriate T cell immune response to gluten is also involved in the pathogenesis of CD, as evidenced by autoantibody switching. The N-glycans released from serum IgG of CD patients and three groups of healthy controls, of differing age ranges, were analysed by NH2-high performance liquid chromatography (HPLC). The fucosylated biantennary N- glycans were the most abundant neutral oligosaccharides; in particular, the agalacto form (G0F) showed a mean value of 42% (s.d. +/- 7.4), 30% (s.d. +/- 5.9), 26% (s.d. +/- 4.2) and 35% (s.d. +/- 6.8) for CD patients, healthy children, healthy adults under 40 and healthy adults over 40 years old, respectively. The ratio of asialo agalacto fucosylated biantenna to asialo monogalacto fucosylated biantenna (G0F)/(G1F) for CD patients showed a significant increase compared to healthy children (P < 0.0002), healthy adults under 40 (P < 0.0002) and healthy adults over 40 years old (P < 0.01). Hypogalactosylation was more pronounced for CD patients than for the patients with other autoimmune diseases such as rheumatoid arthritis or psoriatic arthritis.
Figures



Similar articles
-
IgG subclass profile of serum antigliadin antibodies and antibody-dependent cell-mediated cytotoxicity in young children with coeliac disease.Scand J Immunol. 2001 Jan;53(1):92-8. doi: 10.1046/j.1365-3083.2001.00848.x. Scand J Immunol. 2001. PMID: 11169212
-
Antibody responses to deamidated gliadin peptide show high specificity and parallel antibodies to tissue transglutaminase in developing coeliac disease.Clin Exp Immunol. 2007 Nov;150(2):285-93. doi: 10.1111/j.1365-2249.2007.03487.x. Epub 2007 Sep 4. Clin Exp Immunol. 2007. PMID: 17803713 Free PMC article.
-
Effect of HLA DQ2, dietary exposure and coeliac disease on the development of antibody response to gliadin in children.Scand J Gastroenterol. 2006 Aug;41(8):919-28. doi: 10.1080/00365520500535519. Scand J Gastroenterol. 2006. PMID: 16803690
-
Serology of coeliac disease: early diagnosis and therapeutic impact.Acta Gastroenterol Belg. 1995 Sep-Dec;58(5-6):388-96. Acta Gastroenterol Belg. 1995. PMID: 8775995 Review.
-
Accuracy of diagnostic antibody tests for coeliac disease in children: summary of an evidence report.J Pediatr Gastroenterol Nutr. 2012 Feb;54(2):229-41. doi: 10.1097/MPG.0b013e318216f2e5. J Pediatr Gastroenterol Nutr. 2012. PMID: 22266486 Review.
Cited by
-
Immunoglobulin G N-glycan Biomarkers for Autoimmune Diseases: Current State and a Glycoinformatics Perspective.Int J Mol Sci. 2022 May 6;23(9):5180. doi: 10.3390/ijms23095180. Int J Mol Sci. 2022. PMID: 35563570 Free PMC article. Review.
-
Immunoglobulin G Glycosylation in Diseases.Exp Suppl. 2021;112:395-431. doi: 10.1007/978-3-030-76912-3_13. Exp Suppl. 2021. PMID: 34687018
-
Effects of allergic diseases and age on the composition of serum IgG glycome in children.Sci Rep. 2016 Sep 12;6:33198. doi: 10.1038/srep33198. Sci Rep. 2016. PMID: 27616597 Free PMC article.
-
Galactosylation of serum IgA1 O-glycans in celiac disease.J Clin Immunol. 2011 Feb;31(1):74-9. doi: 10.1007/s10875-010-9473-7. Epub 2010 Oct 12. J Clin Immunol. 2011. PMID: 20938724
References
-
- Fassano A. Celiac disease: the past, the present, the future. Pediatrics. 2001;107:768–70. - PubMed
-
- Sollid LM. Molecular basis of coeliac disease. Annu Rev Immunol. 2000;18:53–81. - PubMed
-
- Sollid LM, Thorsby E. HLA susceptibility genes in coeliac disease: genetic mapping and role in pathogenesis. Gastroenterology. 1993;105:910–22. - PubMed
-
- Schuppan D, Hahn E. Celiac disease and its link to type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2001;14:1–9. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous